Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,312 public trials 521 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Completed

Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia

NCT00905307

Conditions
Disease Attributes, Mental Disorders, Pathologic Processes, +4 more
Locations
  • Study Site Little Rock, Arkansas, United States
  • Study Site Escondido, California, United States
  • Study Site Garden Grove, California, United States
  • Study Site Long Beach, California, United States
View all 73 locations
View Trial Details
Completed

A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment

NCT01007292

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Site US2778 John B. Amos Cancer Center Columbus, Georgia, United States
  • Site US55 Loyola University Hospital - Maywood Maywood, Illinois, United States
  • Site US9 Mount Sinai School of Medicine New York, United States
  • Site US2802 Mecklenburg Medical Group Charlotte, North Carolina, United States
View all 19 locations
View Trial Details
Completed

A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease

NCT00284804

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations
  • City of Hope, National Medical Center Duarte, California, United States
  • California Oncology of the Central Valley Fresno, California, United States
  • University of California, San Diego/Moores UCSD Cancer Center La Jolla, California, United States
  • H. Lee Moffitt Cancer & Research Institute Tampa, Florida, United States
View all 17 locations
View Trial Details
Completed

Pazopanib in Relapsed and Refractory Small Cell Lung Cancer

NCT01713296

Conditions
Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations
  • "Agioi Anargyroi" Anticancer Hospital of Athens Athens, Greece
  • "IASO" General Hospital of Athens Athens, Greece
  • 401 Military Hospital of Athens Athens, Greece
  • Air Forces Military Hospital of Athens Athens, Greece
View Trial Details
Completed

Clofarabine Salvage Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

NCT01295307

Conditions
Acute Myeloid Leukemia, Disease Attributes, Hematologic Diseases, +9 more
Locations
  • HELIOS Klinikum Bad Saarow Bad Saarow, Germany
  • Klinikum Chemnitz gGmbH Chemnitz, Germany
  • University Hospital Carl Gustav Carus Dresden, Germany
  • Universitätsklinikum Erlangen Erlangen, Germany
View Trial Details
Completed

Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

NCT00134004

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Blood Protein Disorders, +63 more
Locations
  • Blood and Marrow Transplant Program at Northside Hospital Atlanta, Georgia, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Hahnemann University Hospital Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions